|
US1019519A
(en)
|
1911-07-11 |
1912-03-05 |
Oscar Martin Polin |
Apparatus for making backing for teeth.
|
|
US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
ATE391492T1
(de)
|
1997-07-29 |
2008-04-15 |
Alcon Lab Inc |
Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat
|
|
EP1051167A1
(en)
|
1998-01-29 |
2000-11-15 |
Sepracor, Inc. |
Pharmaceutical uses of optically pure (-) -bupropion
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
US6451828B1
(en)
|
2000-08-10 |
2002-09-17 |
Elan Pharmaceuticals, Inc. |
Selective inhibition of glutaminase by bis-thiadiazoles
|
|
AU2002305926A1
(en)
|
2001-02-05 |
2002-10-08 |
Exegenics Inc. |
Cysteine protease inhibitors
|
|
US7714139B2
(en)
*
|
2003-03-27 |
2010-05-11 |
Lankenau Institute For Medcial Research |
IDO inhibitors and methods of use
|
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
|
ES2593113T3
(es)
|
2003-08-07 |
2016-12-05 |
Allergan, Inc. |
Composiciones para el suministro de agentes terapéuticos en los ojos y métodos para obtener y usar los mismos
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
JP4885122B2
(ja)
|
2004-04-15 |
2012-02-29 |
ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド |
癌、器官傷害、および筋肉リハビリテーション／運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー
|
|
ES2401557T3
(es)
|
2007-08-02 |
2013-04-22 |
Amgen, Inc |
Moduladores de Pl3 cinasas y métodos de uso
|
|
EP2227233B1
(en)
*
|
2007-11-30 |
2013-02-13 |
Newlink Genetics |
Ido inhibitors
|
|
CN101951930A
(zh)
|
2008-02-19 |
2011-01-19 |
阿奈斯特药品株式会社 |
对身体功能的恢复有用的口服或经肠组合物
|
|
HRP20191433T1
(hr)
*
|
2009-01-26 |
2019-11-15 |
Univ Pennsylvania |
Inhibitori arginaze i metode primjene
|
|
US20130109643A1
(en)
|
2010-05-10 |
2013-05-02 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
|
US10064885B2
(en)
|
2010-07-09 |
2018-09-04 |
Massachusetts Institute Of Technology |
Metabolic gene, enzyme, and flux targets for cancer therapy
|
|
US20120302605A1
(en)
|
2010-11-18 |
2012-11-29 |
Deuteria Pharmaceuticals, Llc |
3-deutero-pomalidomide
|
|
EP2658580A4
(en)
*
|
2010-12-31 |
2014-07-23 |
Corridor Pharmaceuticals Inc |
ARGINE STARTER AND USE METHOD
|
|
CA2742342A1
(en)
|
2011-02-12 |
2012-08-12 |
Baylor Research Institute |
Msh3 expression status determines the responsiveness of cancer cells to the chemotherapeutic treatment with parp inhibitors and platinum drugs
|
|
FI20115876A0
(fi)
|
2011-09-06 |
2011-09-06 |
Turun Yliopisto |
Yhdistelmähoito
|
|
CN103030597B
(zh)
|
2011-09-30 |
2014-10-01 |
南昌滨西科技有限公司 |
肾脏型谷氨酰胺酶抑制剂及其制备方法和用途
|
|
US9266908B2
(en)
*
|
2011-10-19 |
2016-02-23 |
Mars, Incorporated |
Inhibitors of arginase and their therapeutic applications
|
|
HUE047642T2
(hu)
*
|
2011-11-21 |
2020-05-28 |
Calithera Biosciences Inc |
A glutamináz heterociklusos gátlói
|
|
US8604016B2
(en)
|
2011-11-21 |
2013-12-10 |
Calithera Biosciences Inc. |
Heterocyclic inhibitors of glutaminase
|
|
WO2013177426A2
(en)
|
2012-05-24 |
2013-11-28 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
|
|
CA2884103A1
(en)
|
2012-09-10 |
2014-03-13 |
Celgene Corporation |
Methods for the treatment of locally advanced breast cancer
|
|
ES2690829T3
(es)
|
2012-09-17 |
2018-11-22 |
Agios Pharmaceuticals, Inc. |
Uso de e-cadherina y vimentina para la selección de pacientes que responden al tratamiento
|
|
PT2920168T
(pt)
|
2012-11-16 |
2021-10-18 |
Calithera Biosciences Inc |
Inibidores heterocíclicos de glutaminase
|
|
CA2892089A1
(en)
|
2012-11-21 |
2014-05-30 |
Rene M. Lemieux |
Glutaminase inhibitors and methods of use
|
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
|
US9029531B2
(en)
|
2012-11-22 |
2015-05-12 |
Agios Pharmaceuticals, Inc. |
Compounds and their methods of use
|
|
SG11201504184PA
(en)
|
2012-12-03 |
2015-06-29 |
Calithera Biosciences Inc |
Treatment of cancer with heterocyclic inhibitors of glutaminase
|
|
MA38483A1
(fr)
*
|
2013-03-15 |
2018-02-28 |
Bristol Myers Squibb Co |
Inhibiteurs de l'ido
|
|
WO2015061432A1
(en)
|
2013-10-25 |
2015-04-30 |
Calithera Biosciences, Inc. |
Treatment of viral infections with inhibitors of glutaminase
|
|
WO2015061752A1
(en)
|
2013-10-25 |
2015-04-30 |
Pharmacyclics, Inc. |
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
|
|
GB201322725D0
(en)
*
|
2013-12-20 |
2014-02-05 |
Immodulon Therapeutics Ltd |
Cancer therapy
|
|
US20170165364A1
(en)
*
|
2014-02-21 |
2017-06-15 |
Idac Theranostics, Inc. |
Therapeutic agent for solid cancer
|
|
WO2015138902A1
(en)
*
|
2014-03-14 |
2015-09-17 |
Calithera Biosciences, Inc. |
Combination therapy with glutaminase inhibitors
|
|
US10221459B2
(en)
|
2014-05-13 |
2019-03-05 |
Case Western Reserve University |
Compositions and methods of treating cancer harboring PIKC3A mutations
|
|
EA036001B1
(ru)
|
2014-06-13 |
2020-09-11 |
Калитера Байосайенсиз, Инк. |
Комбинация эрлотиниба и ингибитора глутаминазы для лечения рака легких
|
|
US20160002248A1
(en)
|
2014-07-03 |
2016-01-07 |
Board Of Regents, The University Of Texas System |
Gls1 inhibitors for treating disease
|
|
WO2016004418A1
(en)
|
2014-07-03 |
2016-01-07 |
Board Of Regents, University Of Texas System |
Glutaminase inhibitor therapy
|
|
WO2016014890A1
(en)
|
2014-07-24 |
2016-01-28 |
Calithera Biosciences, Inc. |
Treatment of multiple myeloma with heterocyclic inhibitors of glutaminase
|
|
CA2957225A1
(en)
|
2014-08-07 |
2016-02-11 |
Calithera Biosciences, Inc. |
Crystal forms of glutaminase inhibitors
|
|
WO2016054388A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Glutaminase inhibitors
|
|
US10517844B2
(en)
|
2014-11-13 |
2019-12-31 |
Buck Institute For Research On Aging |
Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications
|
|
EP3277276B1
(en)
*
|
2015-03-30 |
2020-11-04 |
Calithera Biosciences, Inc. |
Methods of administering glutaminase inhibitors
|
|
SG11201708153XA
(en)
|
2015-04-06 |
2017-11-29 |
Calithera Biosciences Inc |
Treatment of lung cancer with inhibitors of glutaminase
|
|
EP3328376A4
(en)
|
2015-07-31 |
2019-03-13 |
The Johns Hopkins University |
Methods and compositions for treating metabolic reprogramming disorders
|
|
TW201725044A
(zh)
|
2015-10-01 |
2017-07-16 |
基利科學股份有限公司 |
用於治療癌症之btk抑制劑及查核點抑制劑之組合
|
|
JP6971239B2
(ja)
|
2015-10-05 |
2021-11-24 |
キャリセラ バイオサイエンシーズ， インコーポレイテッド |
グルタミナーゼ阻害剤とイムノオンコロジー薬剤との併用療法
|
|
LT3458053T
(lt)
|
2016-05-20 |
2022-02-25 |
Biohaven Pharmaceutical Holding Company Ltd. |
Riluzolo, rilizolo provaistų arba riluzolo analogų panaudojimas kartu su imunoterapijomis vėžio formų gydymui
|
|
CN109982703A
(zh)
|
2016-08-25 |
2019-07-05 |
卡利泰拉生物科技公司 |
用谷氨酰胺酶抑制剂的组合疗法
|
|
US10278968B2
(en)
|
2016-08-25 |
2019-05-07 |
Calithera Biosciences, Inc. |
Combination therapy with glutaminase inhibitors
|
|
WO2018039442A1
(en)
|
2016-08-25 |
2018-03-01 |
Calithera Biosciences, Inc. |
Treatment of cancer with inhibitors of glutaminase
|
|
KR20190125432A
(ko)
|
2017-03-10 |
2019-11-06 |
칼리테라 바이오사이언시즈, 인코포레이티드 |
글루타미나제 억제제를 사용하는 병용 요법
|
|
US20210177841A1
(en)
*
|
2017-11-03 |
2021-06-17 |
Calithera Biosciences, Inc. |
Conjoint therapy with glutaminase inhibitors
|